Invention Grant
- Patent Title: 4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
- Patent Title (中): 4-恶二唑-2-基-L-吲唑作为P13激酶的抑制剂
-
Application No.: US13254034Application Date: 2010-03-05
-
Publication No.: US08524751B2Publication Date: 2013-09-03
- Inventor: Julie Nicole Hamblin , Zoe Alicia Harrison , Paul Spencer Jones , Suzanne Elaine Keeling , Joelle Le , Christopher James Lunniss , Nigel James Parr
- Applicant: Julie Nicole Hamblin , Zoe Alicia Harrison , Paul Spencer Jones , Suzanne Elaine Keeling , Joelle Le , Christopher James Lunniss , Nigel James Parr
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellecutual Property Development
- Current Assignee: GlaxoSmithKline Intellecutual Property Development
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert J. Smith
- International Application: PCT/EP2010/052835 WO 20100305
- International Announcement: WO2010/102958 WO 20100916
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61K31/416 ; C07D271/10 ; C07D231/56
Abstract:
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
Public/Granted literature
- US20120053166A1 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases Public/Granted day:2012-03-01
Information query
